Figure 5From: A lifeline to treatment: the role of Indian generic manufacturers in supplying antiretroviral medicines to developing countriesPrice trends for generic 3TC/NVP/d4T30 (fixed-dose combination) and innovator 3TC+NVP+d4T30 (3 individual tablets), 2003-2008. *Survey prices provided by innovator companies under tiered-pricing [20]. **2003 price is for three individual ARVs (1st FDC purchase reported in 2004).Back to article page